Covered recipient · General Payments record
DWIGHT D HOOD
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,084.29
- Reported across 149 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $273.59 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $67.04 | 4 |
| Acerta Pharma LLC | $38.48 | 2 |
| Exact Sciences Corporation | $37.71 | 2 |
| Lilly USA, LLC | $33.19 | 2 |
| PFIZER INC. | $23.53 | 1 |
| Novo Nordisk AS | $20.56 | 1 |
| GlaxoSmithKline, LLC. | $19.73 | 1 |
| Astellas Pharma US Inc | $17.73 | 1 |
| Paratek Pharmaceuticals, Inc. | $15.62 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.97 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103936457 | CMS |
| ABBVIE INC. | $22.78 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103936459 | CMS |
| ABBVIE INC. | $13.80 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103936461 | CMS |
| ABBVIE INC. | $14.49 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103936463 | CMS |
| Astellas Pharma US Inc | $17.73 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139300864 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.47 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104598966 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.01 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104589634 | CMS |
| Exact Sciences Corporation | $20.12 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134957433 | CMS |
| Exact Sciences Corporation | $17.59 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134957435 | CMS |
| GlaxoSmithKline, LLC. | $19.73 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116041272 | CMS |
| Lilly USA, LLC | $15.94 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136163592 | CMS |
| Lilly USA, LLC | $17.25 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136163908 | CMS |
| Novo Nordisk Inc | $20.56 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097076102 | CMS |
| Paratek Pharmaceuticals, Inc. | $15.62 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113903827 | CMS |
| PFIZER INC. | $23.53 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130979820 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.